Structural basis of a shared antibody response to SARS-CoV-2 M Yuan, H Liu, NC Wu, CCD Lee, X Zhu, F Zhao, D Huang, W Yu, Y Hua, ... Science 369 (6507), 1119-1123, 2020 | 556 | 2020 |
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants M Yuan, D Huang, CCD Lee, NC Wu, AM Jackson, X Zhu, H Liu, L Peng, ... Science 373 (6556), 818-823, 2021 | 347 | 2021 |
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape PA Koenig, H Das, H Liu, BM Kümmerer, FN Gohr, LM Jenster, ... Science 371 (6530), eabe6230, 2021 | 328 | 2021 |
A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model J Kreye, SM Reincke, HC Kornau, E Sánchez-Sendin, VM Corman, H Liu, ... Cell 183 (4), 1058-1069. e19, 2020 | 327 | 2020 |
Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity H Liu, NC Wu, M Yuan, S Bangaru, JL Torres, TG Caniels, ... Immunity 53 (6), 1272-1280. e5, 2020 | 205 | 2020 |
Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies M Yuan, H Liu, NC Wu, IA Wilson Biochemical and biophysical research communications 538, 192-203, 2021 | 175 | 2021 |
An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain NC Wu, M Yuan, H Liu, CCD Lee, X Zhu, S Bangaru, JL Torres, ... Cell reports 33 (3), 2020 | 153 | 2020 |
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern H Cho, KK Gonzales-Wartz, D Huang, M Yuan, M Peterson, J Liang, ... Science translational medicine 13 (616), eabj5413, 2021 | 92* | 2021 |
A secreted viral nonstructural protein determines intestinal norovirus pathogenesis S Lee, H Liu, CB Wilen, ZE Sychev, C Desai, BL Hykes, RC Orchard, ... Cell host & microbe 25 (6), 845-857. e5, 2019 | 74 | 2019 |
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection H Liu, M Yuan, D Huang, S Bangaru, F Zhao, CCD Lee, L Peng, ... Cell host & microbe 29 (5), 806-818. e6, 2021 | 52 | 2021 |
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease P Zhou, G Song, H Liu, M Yuan, W He, N Beutler, X Zhu, VT Longping, ... Immunity 56 (3), 669-686. e7, 2023 | 48 | 2023 |
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models P Maisonnasse, Y Aldon, A Marc, R Marlin, N Dereuddre-Bosquet, ... Nature communications 12 (1), 6097, 2021 | 44 | 2021 |
Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19 Z Montague, H Lv, J Otwinowski, WS DeWitt, G Isacchini, GK Yip, WW Ng, ... Cell Reports 35 (8), 2021 | 44* | 2021 |
A broad and potent neutralization epitope in SARS-related coronaviruses M Yuan, X Zhu, W He, P Zhou, CI Kaku, T Capozzola, CY Zhu, X Yu, H Liu, ... Proceedings of the National Academy of Sciences 119 (29), e2205784119, 2022 | 42 | 2022 |
Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses W He, R Musharrafieh, G Song, K Dueker, LV Tse, DR Martinez, ... Nature immunology 23 (6), 960-970, 2022 | 42 | 2022 |
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody JL Torres, G Ozorowski, E Andreano, H Liu, J Copps, G Piccini, L Donnici, ... Proceedings of the National Academy of Sciences 119 (20), e2120976119, 2022 | 26 | 2022 |
Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2 X Zhou, F Ma, J Xie, M Yuan, Y Li, N Shaabani, F Zhao, D Huang, NC Wu, ... Cell reports 35 (6), 2021 | 25 | 2021 |
Protective neutralizing epitopes in SARS‐CoV‐2 H Liu, IA Wilson Immunological reviews 310 (1), 76-92, 2022 | 23 | 2022 |
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease P Zhou, G Song, W He, N Beutler, VT Longping, DR Martinez, A Schäfer, ... bioRxiv, 2022 | 22 | 2022 |
Conservation of structure and immune antagonist functions of filoviral VP35 homologs present in microbat genomes MR Edwards, H Liu, RS Shabman, GM Ginell, P Luthra, P Ramanan, ... Cell reports 24 (4), 861-872. e6, 2018 | 22 | 2018 |